EP Patent

EP0661978A1 — Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents

Assigned to Pharmacia and Upjohn Co · Expires 1995-07-12 · 31y expired

What this patent protects

This invention provides a new use of acids, esters, and salts of arylmethylphosphonates of formula (I) or phosphonic acids formula of (II) and derivatives as anti-inflammatory and anti-arthritic agents. Representative compounds include 4-dodecyloxybenzylphosphonic acid dimethyl e…

USPTO Abstract

This invention provides a new use of acids, esters, and salts of arylmethylphosphonates of formula (I) or phosphonic acids formula of (II) and derivatives as anti-inflammatory and anti-arthritic agents. Representative compounds include 4-dodecyloxybenzylphosphonic acid dimethyl ester, (2-naphthalenylmethyl)phosphonic acid dimethyl ester, and ([1,1'-biphenyl]-2-ylmethyl)phosphonic acid dimethyl ester. The invention also provides novel acids, esters, and salts of arylmethylphosphonic acid, phoshonic acid and derivatives.

Drugs covered by this patent

Patent Metadata

Patent number
EP0661978A1
Jurisdiction
EP
Classification
—
Expires
1995-07-12
Drug substance claim
No
Drug product claim
No
Assignee
Pharmacia and Upjohn Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.